← back to search

Avyakta Kallam

University of Nebraska Medical Center · US
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, and CNS Lymphoma Diagnosis and Treatment.
h-index
15
citations
1,504
works
104
NIH funding
—
primary concept
Medicine
email
avyakta.kallam@unmc.edu

Recent publications

Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Blood 2026cited by 0position: middledoi
CTNI-39. TIRABRUTINIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE II PROSPECT STUDY
Neuro-Oncology 2025cited by 0position: middledoi
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2022cited by 161position: middledoi
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network 2022cited by 73position: middledoi
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Blood 2021cited by 94position: middledoi
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers
NEJM Evidence 2021cited by 75position: middledoi
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic
Journal of the National Comprehensive Cancer Network 2021cited by 49position: middledoi
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020
Journal of the National Comprehensive Cancer Network 2020cited by 126position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Reinhold Munker · Tulane University1 papers (2025–2025)Ivana Gojo · Johns Hopkins University1 papers (2021–2021)Martha Wadleigh · University of Alabama at Birmingham1 papers (2021–2021)David M. Johnson · Gilead Sciences (United States)1 papers (2021–2021)Rita Cool · University of Michigan–Ann Arbor1 papers (2021–2021)Jörg Dietrich · Harvard University1 papers (2025–2025)Pamela S. Becker · City Of Hope National Medical Center1 papers (2021–2021)Brian J. Lannutti · Fate Therapeutics (United States)1 papers (2021–2021)Ugonma Chukwueke · University of Alabama at Birmingham1 papers (2025–2025)Paul M. Barr · University of Rochester Medical Center1 papers (2021–2021)— · 1 papers (2025–2025)— · 1 papers (2021–2021)Simon Rule · AstraZeneca (United Kingdom)1 papers (2021–2021)Hong Ren · Guangzhou University of Chinese Medicine1 papers (2021–2021)Elizabeth A. Griffiths · Roswell Park Comprehensive Cancer Center1 papers (2021–2021)Peter Curtin · City of Hope1 papers (2021–2021)Matthew Mei · City Of Hope National Medical Center1 papers (2021–2021)Dawit Aregawi · Pennsylvania State University1 papers (2025–2025)Tracy T. Batchelor · Harvard University1 papers (2025–2025)Wajih Zaheer Kidwai · Yale Cancer Center1 papers (2021–2021)